139 related articles for article (PubMed ID: 16321965)
1. A genomic approach to the identification and characterization of HOXA13 functional binding elements.
McCabe CD; Innis JW
Nucleic Acids Res; 2005; 33(21):6782-94. PubMed ID: 16321965
[TBL] [Abstract][Full Text] [Related]
2. Candidate downstream regulated genes of HOX group 13 transcription factors with and without monomeric DNA binding capability.
Williams TM; Williams ME; Kuick R; Misek D; McDonagh K; Hanash S; Innis JW
Dev Biol; 2005 Mar; 279(2):462-80. PubMed ID: 15733672
[TBL] [Abstract][Full Text] [Related]
3. Hoxd13 and Hoxa13 directly control the expression of the EphA7 Ephrin tyrosine kinase receptor in developing limbs.
Salsi V; Zappavigna V
J Biol Chem; 2006 Jan; 281(4):1992-9. PubMed ID: 16314414
[TBL] [Abstract][Full Text] [Related]
4. Range of HOX/TALE superclass associations and protein domain requirements for HOXA13:MEIS interaction.
Williams TM; Williams ME; Innis JW
Dev Biol; 2005 Jan; 277(2):457-71. PubMed ID: 15617687
[TBL] [Abstract][Full Text] [Related]
5. Hoxa13 regulates expression of common Hox target genes involved in cartilage development to coordinate the expansion of the autopodal anlage.
Yamamoto S; Uchida Y; Ohtani T; Nozaki E; Yin C; Gotoh Y; Yakushiji-Kaminatsui N; Higashiyama T; Suzuki T; Takemoto T; Shiraishi YI; Kuroiwa A
Dev Growth Differ; 2019 Apr; 61(3):228-251. PubMed ID: 30895612
[TBL] [Abstract][Full Text] [Related]
6. Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability.
Williams TM; Williams ME; Heaton JH; Gelehrter TD; Innis JW
Nucleic Acids Res; 2005; 33(14):4475-84. PubMed ID: 16087734
[TBL] [Abstract][Full Text] [Related]
7. Analysis of transcriptional regulation of the small leucine rich proteoglycans.
Tasheva ES; Klocke B; Conrad GW
Mol Vis; 2004 Oct; 10():758-72. PubMed ID: 15496828
[TBL] [Abstract][Full Text] [Related]
8. Footer: a quantitative comparative genomics method for efficient recognition of cis-regulatory elements.
Corcoran DL; Feingold E; Dominick J; Wright M; Harnaha J; Trucco M; Giannoukakis N; Benos PV
Genome Res; 2005 Jun; 15(6):840-7. PubMed ID: 15930494
[TBL] [Abstract][Full Text] [Related]
9. The transcriptional repressor Nkx6.1 also functions as a deoxyribonucleic acid context-dependent transcriptional activator during pancreatic beta-cell differentiation: evidence for feedback activation of the nkx6.1 gene by Nkx6.1.
Iype T; Taylor DG; Ziesmann SM; Garmey JC; Watada H; Mirmira RG
Mol Endocrinol; 2004 Jun; 18(6):1363-75. PubMed ID: 15056733
[TBL] [Abstract][Full Text] [Related]
10. Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter.
Liu M; Whetstine JR; Payton SG; Ge Y; Flatley RM; Matherly LH
Biochem J; 2004 Oct; 383(Pt 2):249-57. PubMed ID: 15214842
[TBL] [Abstract][Full Text] [Related]
11. Wingless signaling induces widespread chromatin remodeling of target loci.
Parker DS; Ni YY; Chang JL; Li J; Cadigan KM
Mol Cell Biol; 2008 Mar; 28(5):1815-28. PubMed ID: 18160704
[TBL] [Abstract][Full Text] [Related]
12. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
Wang GG; Cai L; Pasillas MP; Kamps MP
Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
[TBL] [Abstract][Full Text] [Related]
14. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
15. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S
Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304
[TBL] [Abstract][Full Text] [Related]
16. Identification of a direct Dlx homeodomain target in the developing mouse forebrain and retina by optimization of chromatin immunoprecipitation.
Zhou QP; Le TN; Qiu X; Spencer V; de Melo J; Du G; Plews M; Fonseca M; Sun JM; Davie JR; Eisenstat DD
Nucleic Acids Res; 2004; 32(3):884-92. PubMed ID: 14769946
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor accessibility and histone acetylation of the progesterone receptor gene differs between parental MCF-7 cells and a subline that has lost progesterone receptor expression.
Xu X; Murdoch FE; Curran EM; Welshons WV; Fritsch MK
Gene; 2004 Mar; 328():143-51. PubMed ID: 15019994
[TBL] [Abstract][Full Text] [Related]
18. Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity.
Jia L; Berman BP; Jariwala U; Yan X; Cogan JP; Walters A; Chen T; Buchanan G; Frenkel B; Coetzee GA
PLoS One; 2008; 3(11):e3645. PubMed ID: 18997859
[TBL] [Abstract][Full Text] [Related]
19. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
[TBL] [Abstract][Full Text] [Related]
20. Identification of large-scale molecular changes of Autotaxin(ENPP2) knock-down by small interfering RNA in breast cancer cells.
Noh JH; Ryu SY; Eun JW; Song J; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Lee SN; Nam SW
Mol Cell Biochem; 2006 Aug; 288(1-2):91-106. PubMed ID: 16601922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
